Oral Anticoagulants Market
Oral Anticoagulants Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Oral Anticoagulants Market Size and Growth
The global oral anticoagulants market is anticipated to witness substantial growth due to increasing prevalence of cardiovascular diseases and rising geriatric population. Market size is projected to reach USD 20 billion by 2027. Key players include Bayer AG, Bristol-Myers Squibb, and Johnson & Johnson. Expanding applications in stroke prevention and atrial fibrillation are driving market growth.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Sanofi
◍ Bristol-Myers Squibb
◍ Bayer
◍ Johnson & Johnson
◍ Aspen
◍ Boehringer Ingelheim
◍ Lilly
◍ Daiichi Sankyo
◍ Otsuka
◍ AstraZeneca
Competitive Landscape: The oral anticoagulants market is highly competitive with key players such as Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Aspen, Boehringer Ingelheim, Lilly, Daiichi Sankyo, Otsuka, and AstraZeneca dominating the market.
Overview: These companies offer a range of oral anticoagulant products including warfarin, apixaban, rivaroxaban, dabigatran, and edoxaban. They use various marketing strategies such as partnerships, acquisitions, and product launches to expand their market presence and cater to the increasing demand for oral anticoagulants.
Sales Revenue Figures:
- Sanofi: $41.2 billion
- Bristol-Myers Squibb: $26.7 billion
- Bayer: $41.4 billion
Request Sample Report
Market Segmentation
By Application
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
